Article Information
- Received November 29, 2012
- Revision received August 3, 2013
- Accepted August 7, 2013
- First published September 11, 2013.
- Version of record published September 11, 2013.
Author Information
- Yi Xu1,*,
- Claudia Lopes1,*,
- Hagen Wende2,
- Zhen Guo3,
- Leping Cheng3,
- Carmen Birchmeier2, and
- Qiufu Ma1
- 1Dana-Farber Cancer Institute and Department of Neurobiology, Harvard Medical School, Boston, Massachusetts 02115,
- 2Department of Neuroscience, Max Delbrück Center, 13125 Berlin, Germany, and
- 3Institute of Neuroscience, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
Author contributions
Author contributions: Y.X., C.L., Z.G., L.C., and Q.M. designed research; Y.X., C.L., Z.G., L.C., and Q.M. performed research; H.W. and C.B. contributed unpublished reagents/analytic tools; Y.X., C.L., Z.G., L.C., and Q.M. analyzed data; Y.X., C.L., L.C., C.B., and Q.M. wrote the paper.
↵*Y.X. and C.L. contributed equally to this work.
Disclosures
- Received November 29, 2012.
- Revision received August 3, 2013.
- Accepted August 7, 2013.
The work done in the Q.M. laboratory was supported by the National Institutes of Health, National Institute of Neurological Disorders and Stroke Grant R01NS047710. We thank Dr. Silvia Arber for the Tau-loxp-STOP-lox-mGFP-IRES-NLS-LacZ reporter mice; Dr. Jean-Francois Brunet for the Phox2a antibody; and Drs. Clifford Woolf, Wendy Knowlton, Fu-Chia Yang, and Bo Duan for critical discussions and comments.
The authors declare no competing financial interests.
- Correspondence should be addressed to Dr. Qiufu Ma, Dana-Farber Cancer Institute and Department of Neurobiology, Harvard Medical School, 1 Jimmy Fund Way, Boston, MA 02115. Qiufu_Ma{at}dfci.harvard.edu
Online Impact